Teladoc Announces Second Quarter 2018 Results

Go back to Teladoc Announces Second Quarter 2018 Results

Teladoc (TDOC) PT Raised to $52 at Cantor Fitzgerald Following 2Q

August 2, 2018 8:21 AM EDT

Cantor Fitzgerald raised its price target on Teladoc (NYSE: TDOC) to $52.00 (from $50.00) while maintaining a Neutral rating following the company's 2Q release. Revenue was $94.6 million vs. consensus of $92M. U.S. paid visits grew 41%.

Given the strong growth and including Advance Medical, TDOC... More

Teladoc (TDOC) PT Raised to $77 at Piper Jaffray Following 2Q Report

August 2, 2018 7:13 AM EDT

Piper Jaffray raised its price target on Teladoc (NYSE: TDOC) to $77.00 (from $55.00) while maintaining an Overweight rating following the company's 2Q earnings report. Total revenue of $94.6M was up 112% on an absolute basis and 39% organically, and beat Consensus estimates of $91.9M. EBITDA of... More

Teladoc (TDOC) Misses Q2 EPS by 3c, Revenues Beat; Guides Revs Above

August 1, 2018 4:07 PM EDT

Teladoc (NYSE: TDOC) reported Q2 EPS of ($0.40), $0.03 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $94.6 million versus the consensus estimate of $92.37 million.

GUIDANCE:

Teladoc sees Q3 2018 revenue of $106-108 million, versus the consensus of $105.1... More